Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPGL008 With or Without BCG in Non-muscle-invasive Bladder Cancer
CTR20260629Phase 2Active
- Sponsor
- Shenzhen Saibaoer Biopharmaceutical
- Start
- Mar 2026
- Countries
- 1
01
Overview
A Phase 2 trial of SPGL008 in bladder cancer, sponsored by Shenzhen Saibaoer Biopharmaceutical. Started Mar 2026; status: active.
02
Drugs
SPGL008
03
Conditions
bladder cancer
Beyond the preview
Go deeper on CTR20260629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260629.